• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Quality Improvement Initiative Boosts Early HPV Vaccine Rates

Medically reviewed by Carmen Pope, BPharm. Last updated on May 16, 2024.

By Lori Solomon HealthDay Reporter

THURSDAY, May 16, 2024 -- A multipronged primary care quality improvement initiative increases early human papillomavirus (HPV) vaccine initiation across racial/ethnic, sociodemographic, insurance, and geographic groups, according to a study presented at the annual meeting of the Pediatric Academic Societies, held from May 2 to 6 in Toronto.

Caitlin Miller, from Nemours Children's Health in Delaware Valley, Delaware, and colleagues analyzed trends in early HPV initiation by race/ethnicity, geography, insurance, and child opportunity index. The analysis included data from a primary care network serving 130,000 children.

The researchers found that HPV Healthcare Effectiveness Data and Information Set rate significantly improved annually from a baseline of 49.2 percent in 2019 to 59.5 percent in 2022. Similarly, early HPV initiation (at 9 and 10 years of age) significantly improved from a baseline of 12.7 percent in 2019 to 34.8 percent in 2022. For each racial/ethnic group, early HPV initiation improved significantly from 2019 to 2022. The proportion of patients with early HPV initiation significantly increased for both those covered by Medicaid (19.5 percent in 2019 to 46.2 percent in 2022) and non-Medicaid insurance (8.8 to 39.9 percent). Early HPV initiation significantly increased for both rural residents (1.8 percent in 2019 to 33.1 percent in 2022) and for urban patients (13.7 to 42.7 percent). Across all child opportunity index levels, early HPV initiation increased.

"This multipronged quality improvement approach was instrumental in increasing early HPV initiation in populations with the lowest HPV rates in 2019, such as in rural, Asian, White, and privately insured patients," the authors write.

Abstract

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted May 2024

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.